EUVIMEDEUVIMED entdecken
Scoping ReviewStudienprotokollOpen Access · CC BY-NC-ND 4.0

Remimazolam for sedation and anesthesia in children: Protocol for a scoping review

Vladimir Brüggemann iD, Tom G Hansen iD

Acta Anaesthesiologica Scandinavica · 2024

DOI: 10.1111/aas.14411 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2024. Verfasst von Vladimir Brüggemann und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology & Intensive Care, Akershus University Hospital, Lørenskog, Norway. Hauptthemen laut MEDLINE: Benzodiazepines, Hypnotics and Sedatives, Anesthesia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department Funding Only.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Remimazolam, a novel intravenous benzodiazepine recently approved by both the European Medicines Agency and the Food and Drug Agency, holds significant promise in clinical practice. Its pharmacodynamic profile closely mirrors that of midazolam, while its pharmacokinetics properties bear resemblance to remifentanil. Research in adult populations continues to accumulate, but the pediatric studies' pace is not significant. This scoping review aims to methodically scrutinize published studies, clinical trials, observational research, case reports, and pertinent literature to offer a comprehensive insight into the existing understanding of remimazolam in pediatric sedation and anesthesia. The synthesis of gathered evidence will discern lacunae in the literature, direct forthcoming investigations, and enlighten clinical practices.

Methods

The review will adhere to the guidelines outlined by the Preferred Reporting Items for Systematic Review and Meta‐Analysis (PRISMA) for Scoping Review. A meticulous search strategy will be executed across prominent peer‐reviewed databases, with concerted efforts to identify relevant gray literature. All primary investigations involving the administration of remimazolam in pediatric populations will be encompassed within the scope of this review.

Results

The encompassed studies will be elucidated through a narrative synopsis, complemented by descriptive statistical analyses of quantitative data where deemed applicable.

Conclusion

The planned scoping review aims to delineate the existing evidence regarding the utilization of remimazolam in pediatric anesthesia and sedation. It will discern areas of knowledge deficiency, provide guidance for future inquiries, and enhance clinical practices within the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesHypnotics and SedativesAnesthesiaHumansChildScoping Reviews as Topic

Stichwörter der Autor:innen

Remimazolamanesthesiachildrensedation

Substanzen

remimazolamBenzodiazepinesHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Anaesthesiology & Intensive Care, Akershus University Hospital, Lørenskog, Norway.
  • Faculty of Medicine, Institute of Clinical Medicine, Oslo University, Oslo, Norway.

ORCID-Profile: Vladimir Brüggemann, Tom G Hansen

Förderung

  • Department Funding Only

Zitieren

APA

Brüggemann, V., & Hansen, T. G. (2024). Remimazolam for sedation and anesthesia in children: Protocol for a scoping review. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14411

Vancouver

Brüggemann V, Hansen TG. Remimazolam for sedation and anesthesia in children: Protocol for a scoping review. Acta Anaesthesiologica Scandinavica. 2024. doi:10.1111/aas.14411

BibTeX
@article{Brggemann2024,
  author = {Brüggemann, Vladimir and Hansen, Tom G},
  title = {Remimazolam for sedation and anesthesia in children: Protocol for a scoping review},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2024},
  doi = {10.1111/aas.14411}
}
Kostenlos starten →